Padagis LLC clinical trials
Part of Altaris, LLC.
The registry lists 37 studies whose lead sponsor is Padagis LLC. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Aug 26, 2026.
Our grouping of 1 registry name, not the registry’s. See them and correct one ↓
- 37studies on the registry
- 0open to participants now
What it is testing
The drugs Padagis LLC’s studies test, most studies first; none is open now — 15 drugs with a page of their own. Each count opens the studies in search.
Studies, none open
- Budesonide2 in phase 30 open · 3
- Benzoyl Peroxide2 in phase 30 open · 2
- Clindamycin2 in phase 30 open · 2
- ingenol mebutate2 in phase 30 open · 2
- Adapalene1 in phase 30 open · 1
- 0 open · 1
- brinzolamide1 in phase 30 open · 1
- Ciclopirox1 in phase 30 open · 1
- Estradiol1 in phase 30 open · 1
- Ivermectin1 in phase 30 open · 1
Show 5 moreShow fewer
- 0 open · 1
- Mometasone Furoate1 in phase 30 open · 1
- Mupirocin1 in phase 30 open · 1
- Oxymetazoline1 in phase 30 open · 1
- Roflumilast1 in phase 30 open · 1
All 37 at a glance
Where each study is in its life, its phase and its countries. Each count opens them in search.
- Completed37100%
Over the years
- 07
- 08
- 09
- 10
- 11
- 12
- 13
- 14
- 415
- 16
- 17
- 18
- 19
- 20
- 21
- 22
- 23
- 24
- 25
- 026
By the year each study started; 11 started before 2007. 2026 so far in the lighter column.
Registry sponsor names on this page
Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.
Tell us about a missing company
Each name exactly as ClinicalTrials.gov lists it, and how it relates to Padagis LLC.
- Padagis LLC37 studiesSame company
Something wrong?
Studies
Recruiting first, then most recently updated. Showing 37 of 37.
- Bioequivalence Study of Two Treatments for the Treatment of Plaque PsoriasisCompletedNCT05763082Phase 3
- To Compare the Efficacy and Safety of Perrigo's Product to an FDA Approved Product for the Treatment of Glaucoma or Ocular Hypertension in Both EyesCompletedNCT04944290Phase 3
- Clinical Study Between Two 1% Clindamycin/5% Benzoyl Peroxide Topical Gel FormulationsCompletedNCT01044264Not applicable
- A Randomized Study Evaluating the Therapeutic Equivalence of Two Butoconazole Nitrate Vaginal Cream, 2% FormulationsCompletedNCT01039584Not applicable
- A Relative Bioavailability Study of 100 mg Flavoxate Hydrochloride Tablets Under Fasting ConditionsCompletedNCT00992238Phase 1
- To Compare the Safety and Efficacy of Perrigo's Product to an FDA Approved Product for the Treatment of Glaucoma or Ocular Hypertension in Both EyesCompletedNCT04024072Phase 3
- To Compare the Safety and Efficacy of Perrigo's Product to an FDA Approved Product for the Treatment of Secondarily Infected Traumatic Skin LesionsCompletedNCT04155203Phase 3
- Bioequivalence Study of Budesonide Rectal Aerosol Foam and Uceris® Rectal Aerosol FoamCompletedNCT02800824Phase 1
- Safety Study of Entocort for Children With Crohn's DiseaseCompletedNCT01444092Phase 3
- Safety and Maintenance Study of Entocort for Children With Crohn's DiseaseCompletedNCT01453946Phase 3
- Bioequivalence Study of Two Treatments in the Treatment of Acne Vulgaris on the FaceCompletedNCT03393494Phase 3
- Bioequivalence Study of Two Treatments in the Treatment of Inflammatory Lesions of Rosacea on the FaceCompletedNCT02800148Phase 3
- An Evaluation of the Reduction in Erythema in Adult Patients With Moderate to Severe Persistent Facial Erythema Associated With RosaceaCompletedNCT03352323Phase 3
- Comparative Safety and Efficacy of Two Treatments in the Treatment of Acne VulgarisCompletedNCT02515305Phase 3
- Comparative Safety and Efficacy of Two Treatments in the Treatment of Vulvar and Vaginal AtrophyCompletedNCT02770365Phase 3
- Comparative Safety and Efficacy of Two Treatments in the Treatment of Inflammatory Lesions of RosaceaCompletedNCT02795117Phase 3
- To Compare Safety and Efficacy of Perrigo's Drug Product Compared to an FDA Approved Drug Product in the Treatment of Actinic KeratosisCompletedNCT02385318Phase 3
- To Compare Safety and Efficacy of Perrigo's Drug Compared to an FDA Approved Drug in the Treatment of Actinic KeratosisCompletedNCT02459795Phase 3
- Comparative Safety and Bioequivalence of Two Treatments in the Treatment of Acne VulgarisCompletedNCT02525549Phase 3
- Safety and Equivalence of a Generic Ciclopirox Olamine Topical Suspension Compared to the Reference Ciclopirox Topical Suspension 0.77% for the Treatment of Tinea PedisCompletedNCT00804193Not applicable
- A Study to Compare Clindamycin Phosphate and Benzoyl Peroxide Topical Gel 1.2%/2.5% to Acanya® Topical Gel in the Treatment of Acne VulgarisCompletedNCT01796665Phase 3
- Comparative Safety and Efficacy of Two Rosacea Products in the Treatment of Facial Erythema of RosaceaCompletedNCT02385240Phase 3
- Comparative Safety and Efficacy of Two Steroid Treatments in the Relief of the Symptoms of Seasonal Allergic RhinitisCompletedNCT02230696Phase 3
- Comparative Safety and Efficacy of Two Antiviral Treatments in the Treatment of Recurrent Herpes Simplex LabialisCompletedNCT02265913Phase 3
- A Safety and Bioequivalence of a Mometasone Nasal Spray, 50 mcg/Actuation Compared With Nasonex® Nasal Spray 50 mcg/Actuation in the Relief of the Symptoms of Seasonal Allergic Rhinitis (SAR)CompletedNCT01673659Phase 3
- Bioavailability of Prochlorperazine Suppositories, 25 mgCompletedNCT00992472Phase 1
- Randomized Study to Compare the Bioequivalence of Two Fluticasone Propionate 0.05% Topical CreamsCompletedNCT00803465
- Randomized Study to Compare the Bioavailability of Three Halobetasol Propionate 0.05% Topical CreamsCompletedNCT00803166
- Randomized Study to Compare the Bioavailability of Two Augmented Betamethasone Dipropionate 0.05% Topical CreamsCompletedNCT00800293
- Randomized Study to Compare the Bioavailability of Two Halobetasol Propionate 0.05% Topical OintmentsCompletedNCT00802958
- Randomized Study to Compare the Bioavailability of Two Clobetasol Propionate 0.05% Topical FoamsCompletedNCT00803439
- Randomized Study to Compare the Bioavailability of Two Fluticasone Propionate 0.005% Topical OintmentsCompletedNCT00803218
- Randomized Study to Compare the Bioavailability of Three Mometasone Furoate 0.1% Topical LotionsCompletedNCT00805155
- Bioavailability Study of Two Mesalamine 4 gm/60 ml Rectal Enema FormulationsCompletedNCT00802451Not applicable
- Clinical Study Between Two Clindamycin 1%/Benzoyl Peroxide 5% Topical GelsCompletedNCT01138514Phase 3
- Safety and Equivalence of a Generic Ciclopirox Olamine Cream Compared to the Reference Ciclopirox Cream 0.77% for the Treatment of Tinea PedisCompletedNCT00802672Phase 3
- Safety and Equivalence of a Terconazole Vaginal Suppository (Test Product) Compared to the Reference Terconazole Vaginal Suppository in the Treatment of Vulvovaginal CandidiasisCompletedNCT00803738Not applicable